Lv4
540 积分 2023-12-17 加入
Rational Prediction of PROTAC-compatible Protein-Protein Interfaces by Molecular Docking
24天前
已完结
In Silico Modeling of PROTAC-Mediated Ternary Complexes: Validation and Application
25天前
已完结
Discovery of the First-in-Class Protein Arginine Methyltransferase 1 PROTAC Degrader
1个月前
已完结
Discovery of Novel PROTAC-Based HPK1 Degraders with High Potency and Selectivity for Cancer Immunotherapy
1个月前
已完结
Identification of a Potent and Selective Focal Adhesion Kinase Proteolysis Targeting Chimera: Targeting Noncatalytic Functions of Focal Adhesion Kinase to Facilitate Antitumor Immunity
1个月前
已完结
A novel FAK-degrading PROTAC molecule exhibited both anti-tumor activities and efficient MDR reversal effects
1个月前
已完结
Targeting focal adhesion kinase (FAK) for cancer therapy: FAK inhibitors, FAK-based dual-target inhibitors and PROTAC degraders
1个月前
已完结
Sex Differences in Disease Characteristics and Outcome in Adults with Acute Myeloid Leukemia from China
1个月前
已关闭
JAK3 inhibitors for the treatment of inflammatory and autoimmune diseases: a patent review (2016–present)
1个月前
已完结
Towards precision medicine for AML
1个月前
已完结
皖公网安备34019202002308
